Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Folinic acid pathway" is not a single molecular target but refers broadly to a set of interconnected biochemical reactions involving folinic acid (leucovorin), tetrahydrofolates, and related metabolites. This metabolic network is central to one-carbon transfer reactions required for DNA synthesis/repair and amino acid interconversions. Key enzymes include dihydrofolate reductase and thymidylate synthase; key transporters include reduced folate carrier and proton-coupled folate transporter. Drugs such as methotrexate inhibit parts of this system; others like leucovorin rescue normal cells by bypassing blocked steps. The term "Folinic acid pathway" is imprecise—it does not refer to an established therapeutic target such as an enzyme or receptor but rather describes a functional group of processes essential for cell growth and and division.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Folinic acid pathway.